You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Health related quality of life results through week 22 from the CERTIFI study, a multicenter, randomized, doubleblind, placebocontrolled phase2b study of Ustekinumab in patients with moderately to severely active Crohn's disease: P39.

Sands, BE1; Gasink, C2; Gao, L‐L2; Blank, MA2; Johanns, J2; Guzzo, C2; Chiou, C‐F2; Sandborn, WJ3; Hanauer, SB4; Targan, S5; Rutgeerts, P6; Ghosh, S7; de Villiers, W8; Panaccione, R9; Greenberg, G10; Schreiber, S11; Lichtiger, S1; Feagan, BG12

Inflammatory Bowel Diseases:
Clinical Poster Presentations

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.